Why MyGenius PRO could strengthen Bruker’s position in automated infectious disease diagnostics
Bruker Corporation has launched MyGenius PRO, a high-throughput sample-to-answer molecular diagnostics system, at ESCMID Global 2026 in Europe. The platform enters the infectious disease diagnostics market with IVDR assays for Cytomegalovirus, Epstein-Barr virus, and BK virus, positioning it squarely in transplant and immunocompromised patient testing where automation, turnaround time, and workflow reliability matter commercially as […]